| First Author | Blondin DP | Year | 2020 |
| Journal | Cell Metab | Volume | 32 |
| Issue | 2 | Pages | 287-300.e7 |
| PubMed ID | 32755608 | Mgi Jnum | J:296613 |
| Mgi Id | MGI:6469048 | Doi | 10.1016/j.cmet.2020.07.005 |
| Citation | Blondin DP, et al. (2020) Human Brown Adipocyte Thermogenesis Is Driven by beta2-AR Stimulation. Cell Metab 32(2):287-300.e7 |
| abstractText | Stimulation of brown adipose tissue (BAT) thermogenesis in humans has emerged as an attractive target to improve metabolic health. Pharmacological stimulations targeting the beta3-adrenergic receptor (beta3-AR), the adrenergic receptor believed to mediate BAT thermogenesis, have historically performed poorly in human clinical trials. Here we report that, in contrast to rodents, human BAT thermogenesis is not mediated by the stimulation of beta3-AR. Oral administration of the beta3-AR agonist mirabegron only elicited increases in BAT thermogenesis when ingested at the maximal allowable dose. This led to off-target binding to beta1-AR and beta2-AR, thereby increasing cardiovascular responses and white adipose tissue lipolysis, respectively. ADRB2 was co-expressed with UCP1 in human brown adipocytes. Pharmacological stimulation and inhibition of the beta2-AR as well as knockdown of ADRB1, ADRB2, or ADRB3 in human brown adipocytes all confirmed that BAT lipolysis and thermogenesis occur through beta2-AR signaling in humans (ClinicalTrials.govNCT02811289). |
